Cargando…
Optimization of Short RNA Aptamers for TNBC Cell Targeting
Triple-negative breast cancer (TNBC) is an aggressive cancer with limited targeted therapies. RNA aptamers, suitably chemically modified, work for therapeutic purposes in the same way as antibodies. We recently generated 2′Fluoro-pyrimidines RNA-aptamers that act as effective recognition elements fo...
Autores principales: | Camorani, Simona, d’Argenio, Annachiara, Agnello, Lisa, Nilo, Roberto, Zannetti, Antonella, Ibarra, Luis Exequiel, Fedele, Monica, Cerchia, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998535/ https://www.ncbi.nlm.nih.gov/pubmed/35408872 http://dx.doi.org/10.3390/ijms23073511 |
Ejemplares similares
-
Aptamer-Based Strategies to Boost Immunotherapy in TNBC
por: Agnello, Lisa, et al.
Publicado: (2023) -
TNBC Challenge: Oligonucleotide Aptamers for New Imaging and Therapy Modalities
por: Camorani, Simona, et al.
Publicado: (2018) -
Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells
por: Agnello, Lisa, et al.
Publicado: (2023) -
Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells
por: Camorani, Simona, et al.
Publicado: (2022) -
Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors
por: Agnello, Lisa, et al.
Publicado: (2021)